Shenzhen TargetRx
PrivateLast Round
Series C
Jan 23, 2025
Total Funding Raised
$106M
Company Overview
Shenzhen TargetRx is a clinical-stage pharmaceutical company that specializes in the research and development of targeted small molecule anti-cancer therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shenzhen TargetRx Comparables
Compare Shenzhen TargetRx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nuvalent, Inc. | 78% | |
| Theseus Pharmaceuticals | 78% | |
| Ascentage Pharma Group International | 76% | |
Shenzhen TargetRx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 23, 2025 | ||||
| Strategic | Sep 7, 2024 | ||||
| Series B | Jul 5, 2022 | ||||
| Strategic | Sep 17, 2020 | ||||
| Series A | Apr 30, 2020 | ||||
Pre Seed | Jul 25, 2018 |
Shenzhen TargetRx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oriental Fortune Capital | Series B, Series A |
| CDH Baifu | Series B |
| CCB International | Series B |
| Shenzhen Capital Group | Series B, Pre Seed, Series A |
| Hongtai Fund | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2025
Monthly visitors grew 283% MoM, from 313 to 1.2K.
- Jan 23, 2025
$50M round completed.
Shenzhen TargetRx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Shenzhen TargetRx's valuation, stock price, and market status.